All Stories

  1. Tenders for the Procurement of Medical Devices: Adapting Cost-Effectiveness Rules to the Requirements of the European Public Procurement Directive

    Article • Therapeutic Innovation & Regulatory Science, February 2019, SAGE Publications

    Dr Andrea Messori

  2. Incremental Cost-Effectiveness Ratio and Net Monetary Benefit

    Article • Therapeutic Innovation & Regulatory Science, April 2018, SAGE Publications

    Dr Andrea Messori

  3. Burden of uterine fibroids in Italy: epidemiology, treatment outcomes, and consumption of health care resources in more than 5,000 women [Corrigendum]

    Article • ClinicoEconomics and Outcomes Research, October 2017, Dove Medical Press

    Dr Marco Chiumente, Dr Andrea Messori, Enrica maria Proli

  4. Estimating the 95% confidence interval for survival gain between an experimental anti-cancer treatment and a control

    Article • Therapeutic Advances in Medical Oncology, September 2017, SAGE Publications

    Dr Andrea Messori

  5. Rituximab biosimilar in rheumatoid arthritis: an enhanced-evidence assessment to evaluate equivalence with the originator based on network meta-analysis

    Article • Therapeutic Advances in Musculoskeletal Disease, August 2017, SAGE Publications

    Dr Andrea Messori, Dr Marco Chiumente

  6. Burden of uterine fibroids in Italy: epidemiology, treatment outcomes, and consumption of health care resources in more than 5,000 women

    Article • ClinicoEconomics and Outcomes Research, August 2017, Dove Medical Press

    Dr Marco Chiumente, Dr Andrea Messori, Enrica maria Proli

  7. Pricing of innovative drugs: correlation between incremental cost and survival gain in four countries

    Article • Therapeutic Advances in Medical Oncology, May 2016, SAGE Publications

    Dr Andrea Messori

  8. Corrigendum to “Anti-platelet treatments in acute coronary syndrome: simplified network meta-analysis” [Int J Cardiol Pages 364–367]

    Article • International Journal of Cardiology, September 2014, Elsevier

    Dr Andrea Messori

  9. Glutamine in critically ill patients: Trial-sequential analysis

    Article • Clinical Nutrition, August 2014, Elsevier

    Dr Andrea Messori

  10. Anti-reabsorptive agents in women with osteoporosis: determining statistical equivalence according to evidence-based methods

    Article • Journal of Endocrinological Investigation, July 2014, Springer Science + Business Media

    Dr Andrea Messori

  11. An Italian perspective

    Article • European Journal of Gastroenterology & Hepatology, July 2014, Wolters Kluwer Health

    Dr Andrea Messori

  12. Application of the Gompertz Method for Evaluating Survival Gains in Patients Receiving Cardiac Resynchronization Therapy

    Article • Journal of the American College of Cardiology, July 2014, Elsevier

    Dr Andrea Messori

  13. Biological Drugs for the Treatment of Moderate-to-Severe Psoriasis by Subcutaneous Route: Determining Statistical Equivalence According to Evidence-Based Methods

    Article • Clinical Drug Investigation, June 2014, Springer Science + Business Media

    Dr Andrea Messori

  14. Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes

    Article • Diabetes Therapy, May 2014, Springer Science + Business Media

    Dr Andrea Messori

  15. Intramyocardial bone marrow-derived cells for ischemic heart disease: Is the benefit clinically relevant?

    Article • Atherosclerosis, May 2014, Elsevier

    Dr Andrea Messori

  16. Outcomes with short-term versus long-term antiplatelet dual therapy after drug-eluting stenting: Quantifying the equivalence margins

    Article • International Journal of Cardiology, March 2014, Elsevier

    Dr Andrea Messori

  17. Rates of Inhibitor Development in Previously Untreated Patients with Severe Hemophilia A Treated with Plasma-Derived or Recombinant Factor VIII: No Proof of Difference or Proof of No Difference?

    Article • Seminars in Thrombosis and Hemostasis, February 2014, Thieme Publishing Group

    Dr Andrea Messori

  18. Same-Day Discharge After Percutaneous Coronary Intervention

    Article • Journal of the American College of Cardiology, February 2014, Elsevier

    Dr Andrea Messori

  19. Risk of Myocardial Infarction With Oral Direct Thrombin Inhibitors: Trial Sequential Analysis Based on Two Published Data Sets

    Article • The American Journal of Cardiology, February 2014, Elsevier

    Dr Andrea Messori

  20. Pegylated interferon-α2a versus pegylated interferon-α2b in hepatitis C

    Article • European Journal of Gastroenterology & Hepatology, February 2014, Wolters Kluwer Health

    Dr Andrea Messori

  21. Risk of intracranial haemorrhage in patients with atrial fibrillation treated with novel oral anticoagulants: testing the equivalence margins between dabigratran, rivaroxaban and apixaban

    Article • European Journal of Clinical Pharmacology, January 2014, Springer Science + Business Media

    Dr Andrea Messori

  22. Are Newer-Generation Drug-Eluting Stents More Effective in Women than Early-Generation Ones?

    Article • World Journal of Cardiovascular Diseases, January 2014, Scientific Research Publishing, Inc,

    Dr Andrea Messori

  23. Parenteral vs oral iron in patients with inflammatory bowel disease: Quantifying information size by trial sequential analysis

    Article • Journal of Crohn s and Colitis, November 2013, Oxford University Press (OUP)

    Dr Andrea Messori

  24. Intra-aortic balloon pump in high-risk percutaneous coronary interventions without cardiogenic shock: Trial sequential analysis of outcomes

    Article • International Journal of Cardiology, October 2013, Elsevier

    Dr Andrea Messori

  25. Effectiveness of drug-eluting balloons: Quantifying the information size from clinical trials

    Article • International Journal of Cardiology, October 2013, Elsevier

    Dr Andrea Messori

  26. The need to know crude event rates in meta-analysis

    Article • American Heart Journal, September 2013, Elsevier

    Dr Andrea Messori

  27. Müllerian Adenosarcoma: A Frequently Misinterpreted Diagnosis

    Article • Journal of Minimally Invasive Gynecology, September 2013, Elsevier

    Dr Andrea Messori

  28. Dabigatran in atrial fibrillation

    Article • Journal of Cardiovascular Medicine, September 2013, Wolters Kluwer Health

    Dr Andrea Messori

  29. Off-pump versus on-pump coronary artery bypass grafting: Quantifying information size by trial sequential analysis

    Article • European Journal of Internal Medicine, September 2013, Elsevier

    Dr Andrea Messori

  30. Omega-3 polyunsaturated fatty acids for patients at risk of sudden cardiac death and ventricular arrhythmias: Trial sequential analysis

    Article • Heart & Lung, September 2013, Elsevier

    Dr Andrea Messori

  31. Intracoronary Infusion of Bone-marrow Derived Mononuclear Cells in Acute Myocardial Infarction: Are Outcomes Influenced by the Number of Infused Cells?

    Article • Heart Lung and Circulation, September 2013, Elsevier

    Dr Andrea Messori

  32. ω-3 Fatty Acid Supplements for Secondary Prevention of Cardiovascular Disease: From “No Proof of Effectiveness” to “Proof of No Effectiveness”

    Article • JAMA Internal Medicine, August 2013, American Medical Association (AMA)

    Dr Andrea Messori

  33. Erythropoietin in Patients With Acute Myocardial Infarction: No Proof of Effectiveness or Proof of No Effectiveness?

    Article • Clinical Cardiology, August 2013, Wiley

    Dr Andrea Messori

  34. Erythropoiesis‐stimulating agents in heart failure: no proof of effectiveness or proof of no effectiveness?

    Article • European Journal of Heart Failure, August 2013, Wiley

    Dr Andrea Messori

  35. Temporal trend of short-term mortality in severely ill patients receiving parenteral glutamine supplementation

    Article • Clinical Nutrition, June 2013, Elsevier

    Dr Andrea Messori

  36. Comparing new anticoagulants in atrial fibrillation using the number needed to treat

    Article • European Journal of Internal Medicine, June 2013, Elsevier

    Dr Andrea Messori

  37. Viscosupplementation in patients with knee osteoarthritis: temporal trend of benefits assessed by meta-regression

    Article • European Journal of Orthopaedic Surgery & Traumatology, May 2013, Springer Science + Business Media

    Dr Andrea Messori

  38. Mechanical Endovascular Therapy in Ischaemic Stroke: Temporal Trend of Outcomes

    Article • International Journal of Stroke, May 2013, SAGE Publications

    Dr Andrea Messori

  39. Acute lymphoblastic leukemia in first complete remission: temporal trend of outcomes in studies comparing allogeneic transplant with autologous transplant or chemotherapy

    Article • Annals of Hematology, May 2013, Springer Science + Business Media

    Dr Andrea Messori

  40. Association between migraine and cardiovascular mortality: Is there a temporal trend?

    Article • Cephalalgia, April 2013, SAGE Publications

    Dr Andrea Messori

  41. New Endovascular Devices for Acute Ischemic Stroke: Summarizing Evidence by Multiple Treatment Comparison Meta-Analysis

    Article • Annals of Vascular Surgery, April 2013, Elsevier

    Dr Andrea Messori

  42. Between-Study Variability of Short-term Mortality in Patients With Pararenal Aortic Pathologies Treated With Chimney or Fenestrated Endografts

    Article • Journal of Endovascular Therapy, April 2013, International Society of Endovascular Specialists

    Dr Andrea Messori

  43. Treatments for non‐Hodgkin lymphoma in HIV‐positive patients: Quantifying incremental benefit from 1993 to 2004 by metaregression

    Article • American Journal of Hematology, March 2013, Wiley

    Dr Andrea Messori

  44. Using risk difference as opposed to odds-ratio in meta-analysis

    Article • International Journal of Cardiology, March 2013, Elsevier

    Dr Andrea Messori

  45. Outcomes in Patients With Unprotected Left Main Coronary Disease: Comparison Between Drug-Eluting Stents and Coronary Artery By-Pass Grafting

    Article • The American Journal of Cardiology, March 2013, Elsevier

    Dr Andrea Messori

  46. All-Cause Mortality in Patients With Unprotected Left Main Coronary Disease: Comparison Between Stenting and Coronary Artery Bypass Grafting

    Article • The American Journal of Cardiology, March 2013, Elsevier

    Dr Andrea Messori

  47. New and old anti-thrombotic treatments for patients with atrial fibrillation

    Article • International Journal of Clinical Pharmacy, January 2013, Springer Science + Business Media

    Dr Andrea Messori

  48. Maintenance Chemotherapy in Ovarian Cancer: A Trial-Sequential Analysis

    Article • Journal of Cancer Therapy, January 2013, Scientific Research Publishing, Inc,

    Dr Andrea Messori

  49. Does network meta-analysis generate any new knowledge?

    Article • Thrombosis and Haemostasis, December 2012, Schattauer GmbH

    Dr Andrea Messori

  50. Meta-Analysis of Observational Studies to Evaluate Immediate Outcomes After Endarterectomy or Stenting for Carotid Artery Stenosis

    Article • Annals of Vascular Surgery, November 2012, Elsevier

    Dr Andrea Messori

  51. Temporal Trend of Overall Survival in Patients with Advanced Non-small Cell Lung Cancer Given First-Line Cytotoxic Treatments

    Article • Lung, October 2012, Springer Science + Business Media

    Dr Andrea Messori

  52. Antipsychotic drugs for relapse prevention in schizophrenia

    Article • The Lancet, September 2012, Elsevier

    Dr Andrea Messori

  53. Defining innovations of therapeutic interventions: a position paper by the Italian Society of Hospital Pharmacists

    Article • International Journal of Clinical Pharmacy, March 2012, Springer Science + Business Media

    Dr Andrea Messori

  54. Immediate and late outcome of patients aged 80 years and older undergoing isolated aortic valve replacement: A systematic review and meta-analysis of 48 studies

    Article • American Heart Journal, March 2012, Elsevier

    Dr Andrea Messori

  55. Interpreting randomised trials evaluating newer agents or interferon in multiple sclerosis

    Article • European Journal of Clinical Pharmacology, February 2012, Springer Science + Business Media

    Dr Andrea Messori

  56. Effect of discounting on estimation of benefits determined by hepatitis C treatment

    Article • World Journal of Gastroenterology, January 2012, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Andrea Messori

  57. Nationwide prediction of future expenditure for protease inhibitors in chronic hepatitis C

    Article • Digestive and Liver Disease, January 2012, Elsevier

    Dr Andrea Messori

  58. Treatments for relapsing–remitting multiple sclerosis: summarising current information by network meta-analysis

    Article • European Journal of Clinical Pharmacology, November 2011, Springer Science + Business Media

    Dr Andrea Messori

  59. Anti-platelet treatments in acute coronary syndrome: Simplified network meta-analysis

    Article • International Journal of Cardiology, August 2011, Elsevier

    Dr Andrea Messori

  60. Definizione di farmaco innovativo: rivisitazione in un contesto di risorse limitate

    Article • PharmacoEconomics Italian Research Articles, July 2011, Springer Science + Business Media

    Dr Andrea Messori

  61. Treatments for macular degeneration: summarising evidence using network meta-analysis

    Article • British Journal of Ophthalmology, June 2011, BMJ

    Dr Andrea Messori

  62. First-line treatments for hepatitis C

    Article • Alimentary Pharmacology & Therapeutics, May 2011, Wiley

    Dr Andrea Messori

  63. The Role of Bortezomib, Thalidomide and Lenalidomide in the Management of Multiple Myeloma

    Article • PharmacoEconomics, April 2011, Springer Science + Business Media

    Dr Andrea Messori

  64. Results can be summarised in a simple figure

    Article • BMJ, March 2011, BMJ

    Dr Andrea Messori

  65. Un’esigenza di chiarezza: differenziare il payback “value-based” da quello non “value-based”

    Article • PharmacoEconomics Italian Research Articles, November 2010, Springer Science + Business Media

    Dr Andrea Messori

  66. Long-term dual antiplatelet therapy after percutaneous coronary intervention

    Article • Heart, September 2010, BMJ

    Dr Andrea Messori

  67. Relating price determination to disease prevalence

    Article • BMJ, August 2010, BMJ

    Dr Andrea Messori

  68. Outcome based schemes are more common than you think

    Article • BMJ, July 2010, BMJ

    Dr Andrea Messori

  69. Randomized Study of Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Inappropriate Conclusions

    Article • American Journal of Ophthalmology, May 2010, Elsevier

    Dr Andrea Messori

  70. Risk‐sharing approach for managing factor VIIa reimbursement in haemophilia patients with inhibitors

    Article • Haemophilia, April 2010, Wiley

    Dr Andrea Messori

  71. Emerging transcatheter therapies for aortic and mitral disease

    Article • Heart, September 2009, BMJ

    Dr Andrea Messori

  72. Left ventricular assist device as destination therapy: Application of the payment-by-results approach for the device reimbursement

    Article • Journal of Thoracic and Cardiovascular Surgery, August 2009, Elsevier

    Dr Andrea Messori, Professor Massimo Bonacchi

  73. Inappropriate comparison of survival rates at 30 days in transplanted patients previously implanted or not with left ventricular assist devices

    Article • Journal of Thoracic and Cardiovascular Surgery, March 2009, Elsevier

    Dr Andrea Messori

  74. Cost Effectiveness of Sunitinib

    Article • Journal of Clinical Oncology, November 2008, American Society of Clinical Oncology (ASCO)

    Dr Andrea Messori

  75. High‐density polyethylene reinforced with submicron titania particles

    Article • Polymer Engineering & Science, January 2008, Wiley

    Dr Andrea Messori, Professor Federica Bondioli

  76. Effect of Food on Lapatinib Pharmacokinetics

    Article • Journal of Clinical Oncology, November 2007, American Society of Clinical Oncology (ASCO)

    Dr Andrea Messori

  77. PPRS is not NICE

    Article • BMJ, September 2007, BMJ

    Dr Andrea Messori

  78. Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohnʼs disease patients: A project of the European Collaborative Study Group on Inflammatory Bowel Disease

    Article • Inflammatory Bowel Diseases, July 2007, Oxford University Press (OUP)

    Dr Andrea Messori

  79. Heterogeneity in the evaluation of observational studies by Italian ethics committees

    Article • February 2005, Springer Science + Business Media

    Dr Andrea Messori

  80. Clinical-economic appropriateness of drug treatments: designing a method that combines evidence-based information and cost assessments to construct league tables accounting for the potential number of patients

    Article • Expert Opinion on Pharmacotherapy, November 2004, Informa Healthcare

    Dr Andrea Messori

  81. Factors influencing the length of hospitalisation in intensive care units: a prospective observational study

    Article • Pharmacy World & Science, October 2004, Springer Science + Business Media

    Dr Andrea Messori

  82. New Drugs for Rheumatoid Arthritis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2004, New England Journal of Medicine (NEJM/MMS)

    Dr Andrea Messori

  83. Guadagno di sopravvivenza dei nuovi farmaci

    Article • PharmacoEconomics Italian Research Articles, July 2004, Springer Science + Business Media

    Dr Andrea Messori

  84. Beneficio clinico e prezzo dei farmaci

    Article • PharmacoEconomics Italian Research Articles, March 2004, Springer Science + Business Media

    Dr Andrea Messori

  85. Prevention of coronary heart disease

    Article • BMJ, February 2004, BMJ

    Dr Andrea Messori

  86. Dropout rates with olanzapine or risperidone: a multi-centre observational study

    Article • European Journal of Clinical Pharmacology, February 2004, Springer Science + Business Media

    Dr Andrea Messori

  87. "Polypill" to fight cardiovascular disease: Cost effectiveness of statins for primary prevention of cardiovascular events is questionable

    Article • BMJ, October 2003, BMJ

    Dr Andrea Messori

  88. Controvalore economico del farmaco e beneficio clinico: stato dell’arte della metodologia e applicazione di un algoritmo farmacoeconomico

    Article • PharmacoEconomics Italian Research Articles, July 2003, Springer Science + Business Media

    Dr Andrea Messori

  89. Pharmacotherapy of multiple myeloma: an economic perspective

    Article • Expert Opinion on Pharmacotherapy, April 2003, Informa Healthcare

    Dr Andrea Messori

  90. Clinical Trial Response and Dropout Rates with Olanzapine versus Risperidone

    Article • Annals of Pharmacotherapy, April 2003, SAGE Publications

    Dr Andrea Messori

  91. Comparative Effectiveness of Antipsychotic Drugs

    Article • American Journal of Psychiatry, March 2003, American Psychiatric Association

    Dr Andrea Messori

  92. Survival of Patients with Recurrent???Malignant Glioma Treated???with Temozolomide

    Article • Drugs in R&D, January 2003, Springer Science + Business Media

    Dr Andrea Messori

  93. PNP8 ADJUNCTIVE TOPIRAMATE THERAPY IN PATIENTS WITH REFRACTORY SEIZURES:A LIFETIME COST-UTILITY ANALYSIS

    Article • Value in Health, November 2002, Elsevier

    Dr Andrea Messori

  94. Quality of Life and Utility in Patients with Non-Small Cell Lung Cancer

    Article • PharmacoEconomics, January 2001, Springer Science + Business Media

    Dr Andrea Messori

  95. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled

    Article • BMJ, November 2000, BMJ

    Dr Andrea Messori

  96. Survival Meta-Analysis of Individual Patient Data and Survival Meta-Analysis of Published (Aggregate) Data

    Article • Clinical Drug Investigation, November 2000, Springer Science + Business Media

    Dr Andrea Messori

  97. Survival in patients with metastatic breast cancer: analysis of randomized studies comparing oral aromatase inhibitors versus megestrol

    Article • Anti-Cancer Drugs, October 2000, Wolters Kluwer Health

    Dr Andrea Messori

  98. Biliary stents in neoplastic strictures: plastic versus metal throughout evidence based medicine

    Article • The American Journal of Gastroenterology, September 2000, Wolters Kluwer Health

    Dr Andrea Messori

  99. A new method for expressing survival and life expectancy in lifetime cost-effectiveness studies that evaluate cancer patients (review).

    Article • Oncology Reports, September 1999, Spandidos Publications

    Dr Andrea Messori

  100. Cost Effectiveness of Riluzole in Amyotrophic Lateral Sclerosis

    Article • PharmacoEconomics, January 1999, Springer Science + Business Media

    Dr Andrea Messori

  101. PMC3: SURVIVAL GAINS AND DEGREE OF THERAPEUTIC INNOVATION

    Article • Value in Health, January 1999, Elsevier

    Dr Andrea Messori

  102. W7: HANDLING SURVIVAL DATA IN COST-EFFECTIVENESS ANALYSIS

    Article • Value in Health, January 1999, Elsevier

    Dr Andrea Messori

  103. PCA6: COST-EFFECTIVENESS OF GEMCITABINE AS FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED PANCREATIC CANCER

    Article • Value in Health, January 1999, Elsevier

    Dr Andrea Messori

  104. CAN1: COST-EFFECTIVENESS ANALYSIS OF HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC RESCUE AS PRIMARY TREATMENT FOR METASTATIC BREAST CANCER

    Article • Value in Health, January 1999, Elsevier

    Dr Andrea Messori

  105. CAN2: A NEW METHOD FOR EXPRESSING SURVIVAL AND LIFE EXPECTANCY IN CANCER PATIENTS

    Article • Value in Health, January 1999, Elsevier

    Dr Andrea Messori

  106. Pharmacoeconomic profile of taxanes in advanced ovarian cancer

    Article • Anti-Cancer Drugs, November 1998, Wolters Kluwer Health

    Dr Andrea Messori

  107. Maintenance Treatment with Interferon in Multiple Myeloma

    Article • Clinical Drug Investigation, November 1997, Springer Science + Business Media

    Dr Andrea Messori

  108. Pharmacoeconomic profile of paclitaxel as a first-line treatment for patients with advanced ovarian carcinoma

    Article • Cancer, June 1997, Wiley

    Dr Andrea Messori

  109. Drug Treatments for Maintaining Remission in Crohnʼs Disease

    Article • PharmacoEconomics, May 1997, Springer Science + Business Media

    Dr Andrea Messori

  110. Cost-Effectiveness of Interferon-α as Maintenance Therapy in Chronic Myelogenous Leukemia

    Article • Annals of Internal Medicine, April 1997, American College of Physicians

    Dr Andrea Messori

  111. Survival curve fitting using the Gompertz function: a methodology for conducting cost-effectiveness analyses on mortality data

    Article • Computer Methods and Programs in Biomedicine, March 1997, Elsevier

    Dr Andrea Messori

  112. Erratum to: Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide + methotrexate + fluorouracil in patients with node-positive breast cancer

    Article • European Journal of Clinical Pharmacology, January 1997, Springer Science + Business Media

    Dr Andrea Messori

  113. Cost Effectiveness of Adjuvant Intraportal Chemotherapy in Patients with Colorectal Cancer

    Article • Journal of Clinical Gastroenterology, December 1996, Wolters Kluwer Health

    Dr Andrea Messori

  114. Pharmacoeconomic profile of paclitaxel as a first-line treatment for patients with advanced ovarian carcinoma: A lifetime cost-effectiveness analysis

    Article • Cancer, December 1996, Wiley

    Dr Andrea Messori

  115. Pharmacoeconomic profile of paclitaxel as a first‐line treatment for patients with advanced ovarian carcinoma: A lifetime cost‐effectiveness analysis

    Article • Cancer, December 1996, Wiley

    Dr Andrea Messori

  116. Intermittent negative pressure ventilation in the treatment of hypoxic hypercapnic coma in chronic respiratory insufficiency.

    Article • Thorax, November 1996, BMJ

    Dr Andrea Messori

  117. Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide + methotrexate + fluorouracil in patients with node-positive breast cancer

    Article • European Journal of Clinical Pharmacology, October 1996, Springer Science + Business Media

    Dr Andrea Messori

  118. Effectiveness of Immunoglobulins for the Prevention of Systemic Infections

    Article • Clinical Drug Investigation, December 1995, Springer Science + Business Media

    Dr Andrea Messori

  119. Effectiveness of gabexate mesilate in acute pancreatitis

    Article • Digestive Diseases and Sciences, April 1995, Springer Science + Business Media

    Dr Andrea Messori

  120. Cisplatin Pharmacokinetics Using a Five-Day Schedule During Repeated Courses of Chemotherapy in Germ Cell Tumors

    Article • Therapeutic Drug Monitoring, February 1995, Wolters Kluwer Health

    Dr Andrea Messori

  121. EXAFS studies of Fe(III)-phosvitin at high metal to protein ratios

    Article • BioMetals, April 1994, Springer Science + Business Media

    Dr Andrea Messori, Professor Stefano Mangani

  122. Meta-analysis on the Maintenance of Remission in Crohnʼs Disease

    Article • Journal of Clinical Gastroenterology, September 1993, Wolters Kluwer Health

    Dr Andrea Messori

  123. Pharmacokinetics, thrombogenicity and safety of a double-treated prothrombin complex concentrate

    Article • Thrombosis Research, August 1993, Elsevier

    Dr Andrea Messori

  124. Meta-analysis of clinical trials based on censored end-points: simplified theory and implementation of the statistical algorithms on a microcomputer

    Article • Computer Methods and Programs in Biomedicine, August 1993, Elsevier

    Dr Andrea Messori

  125. Calculation Errors in Meta-Analysis

    Article • Annals of Internal Medicine, January 1993, American College of Physicians

    Dr Andrea Messori

  126. Antibiotics Secretion into Pancreatic Fluid

    Article • January 1992, Springer Science + Business Media

    Dr Andrea Messori

  127. New Schedule of Administration in the Treatment of Acute Myeloid Leukemia

    Article • Leukemia & Lymphoma, January 1992, Taylor & Francis

    Dr Andrea Messori

  128. Clinical Features, Pathogenesis and Management of Drug-Induced Seizures

    Article • Drug Safety, January 1990, Springer Science + Business Media

    Dr Andrea Messori

  129. Bioavailability of Intramuscular Ciclosporin in the Pig

    Article • European Surgical Research, January 1990, Karger Publishers

    Dr Andrea Messori

  130. Ofloxacin penetration into bile and pancreatic juice

    Article • Journal of Antimicrobial Chemotherapy, January 1989, Oxford University Press (OUP)

    Dr Andrea Messori

  131. Clinical Pharmacokinetics of Valproic Acid - 1988

    Article • Clinical Pharmacokinetics, December 1988, Springer Science + Business Media

    Dr Andrea Messori

  132. PROGNOSTIC FACTORS IN HODGKIN'S DISEASE

    Article • The Lancet, May 1988, Elsevier

    Dr Andrea Messori

  133. 13-cis-Retinoic Acid Treatment in Patients with Myelodysplastic Syndrome

    Article • Acta Haematologica, January 1988, Karger Publishers

    Dr Andrea Messori

  134. Clinical Pharmacokinetics of Factor VIII in Patients with Classic Haemophilia

    Article • Clinical Pharmacokinetics, December 1987, Springer Science + Business Media

    Dr Andrea Messori

  135. Single‐dose pharmacokinetics of Factor IX evaluated by model‐independent methods

    Article • European Journal Of Haematology, November 1987, Wiley

    Dr Andrea Messori

  136. Ciprofloxacin Penetration in Pancreatic Juice

    Article • Chemotherapy, January 1987, Karger Publishers

    Dr Andrea Messori

  137. Changes in immunoreactive β-endorphin, methionine-enkephalin and ACTH in bone marrow cells and fluid from leukemic children

    Article • Clinical Immunology and Immunopathology, November 1986, Elsevier

    Dr Andrea Messori

  138. HALF-LIFE AND IN-VIVO RECOVERY OF HEATED FACTOR VIII CONCENTRATES

    Article • The Lancet, September 1986, Elsevier

    Dr Andrea Messori

  139. Pharmacokinetics of a new heat-treated concentrate of factor VIII estimated by model-independent methods

    Article • Thrombosis Research, May 1986, Elsevier

    Dr Andrea Messori

  140. A calculator program for clinical application of the Bayesian method of predicting plasma drug levels

    Article • Computer Programs in Biomedicine, January 1985, Elsevier

    Dr Andrea Messori

  141. Rifampicin concentrations in pancreatic juice

    Article • Journal of Antimicrobial Chemotherapy, January 1985, Oxford University Press (OUP)

    Dr Andrea Messori

  142. INDIVIDUALIZATION OF FACTOR VIII DOSAGE

    Article • Journal of Clinical Pharmacy and Therapeutics, April 1984, Hindawi Publishing Corporation

    Dr Andrea Messori

  143. A calculator program for least-squares parameter estimation according to the one-compartment kinetic model with zero-order input

    Article • Computer Programs in Biomedicine, February 1984, Elsevier

    Dr Andrea Messori

  144. COMPARATIVE ANALYSIS OF THE PHARMACOKINETIC TECHNIQUES AVAILABLE FOR INDIVIDUALIZING PHENYTOIN DOSAGE

    Article • Journal of Clinical Pharmacy and Therapeutics, August 1983, Hindawi Publishing Corporation

    Dr Andrea Messori

  145. Clinical studies of pharmacodynamic interactions between antiepileptic drugs and other drugs

    Article • Cambridge University Press

    Dr Andrea Messori